April 2026 was a loud month for healthcare enforcement in California. On April 9, the California Attorney General charged 21 defendants in a $267 million Medi-Cal hospice fraud scheme involving stolen identities and shell providers. On April 15, the White House–led Task Force to Eliminate Fraud — created by executive order on March 16, coordinating DOJ, HHS, DHS, and Labor — suspended Medicare payments for 447 hospices and 23 home health agencies in the greater Los Angeles area, an estimated $600 million in suspected fraud. On April 30, the DOJ stood up a new West Coast Health Care Fraud Strike Force covering Arizona, Nevada, and Northern California, staffed with 10+ dedicated prosecutors.
If your agency is outside California, the specific actions may feel distant. The enforcement mechanism they used is not.
How 42 CFR 405.371 actually works
The California suspensions arrived as letters from Qlarant Integrity Solutions, LLC — CMS's zone program integrity contractor. The legal authority is 42 CFR 405.371: CMS may suspend Medicare payments when it receives a "credible allegation of fraud." That standard does not require a criminal charge, a conviction, or a completed audit. Anomalous billing patterns identified through routine data review — elevated live discharge rates, claim frequency outliers, visit patterns that don't align with OASIS scores — can constitute a credible allegation.
When payments are suspended, funds accumulate in a suspense account while the investigation runs. Cash flow stops the day the letter arrives. If the investigation ultimately finds an overpayment, the suspense balance is applied first. If the allegation doesn't hold, funds are eventually released — but the process runs in months. Providers have a 15-day window to submit a written rebuttal under 42 CFR 405.372(b)(2). A rebuttal must be factual and document-specific; "this is a mistake" does not qualify.
The primary trigger in the LA letters was an elevated live discharge rate — any rate above roughly 40%, against a national hospice average near 17–18%. For home health, the analogous integrity contractor flags are: visit frequency outliers vs. HIPPS group benchmarks, OASIS functional scores that don't support billed diagnoses, and re-admission rates without documented change-of-condition.
Why this matters for every HHA, not just California agencies
The Congressional response has already gone national. House Energy and Commerce Committee chairmen wrote the HHS OIG specifically about "ongoing HHA and hospice fraud in Los Angeles County" — framing this as an HHA oversight gap, not only a hospice one. The West Coast Strike Force lists wound care as a named enforcement priority alongside hospice and sober homes; wound care is one of the largest visit-category overlaps with skilled home health. And the Task Force infrastructure itself is multistate by design — it is not a California program.
The fraud pattern that drove most of the LA suspensions — shell or newly enrolled providers billing at high volumes without clinical infrastructure to support it — surfaced clearly in the enrollment data: 310 home health agencies enrolled in Medicare in LA County in 2025 alone. Integrity contractors watch enrollment spikes in markets with known fraud displacement.
What your agency should do now
- Review your claim-pattern outliers relative to your HIPPS group. High visit frequency in a low-complexity HIPPS group, or LUPAs clustered just above threshold, are exactly the patterns that surface in billing-anomaly reviews. Know where you stand before a contractor does.
- Audit OASIS-to-diagnosis alignment on a sample of recent episodes. Suspension trigger criteria focus on billing patterns that don't have clinical support. If your HIPPS codes and the OASIS functional picture don't hang together, that's a flag.
- Verify your referral documentation has Anti-Kickback safe-harbor coverage. Kickback arrangements were a core allegation in the California actions. Any arrangement with a referral source — marketing employment, consulting agreements with facilities — needs documented safe-harbor analysis.
- Know your rebuttal rights and have legal counsel identified now. The 15-day rebuttal window under 42 CFR 405.372(b)(2) is short. Counsel with Medicare enforcement experience needs to be reachable before a Qlarant letter ever arrives, not after.
What we built for this
Carelytic's AI Pre-Sign QA flags every OASIS where functional scores, billed diagnoses, and the visit plan don't form a coherent clinical picture — before the claim goes out. Every code suggestion cites the specific chart text that supports it. Clinician acceptances and overrides are logged with timestamps and reason codes. If a zone program integrity contractor requests records, the audit trail is already built. The best response to a credible-allegation suspension is documentation that was constructed correctly from the first visit — not a legal argument assembled after the cash stops flowing.
This post is editorial commentary on publicly reported industry news, not legal or compliance advice. For your agency's specific situation, consult counsel and your CMS regional office.